Impact of micellar vehicles on in situ intestinal absorption properties of beta-lapachone in rats

Korean Journal of Physiology and Pharmacology

Volumn 17, Issue 1, 2013, Pages 9-13

  Jang, Soung Baek ^a   Kim, Dongju ^a   Kim, Seong Yeon ^a   Park, Changhee ^a   Jeong, Ji Hoon ^a   Kuh, Hyo Jeong ^b   Lee, Jaehwi ^a  

^a Chung Ang University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Beta lapachone; Mixed micelles; Permeability; Single pass intestinal perfusion

Indexed keywords

BETA LAPACHONE; DEOXYCHOLATE SODIUM; DODECYL SULFATE SODIUM; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE PERMEABILITY; DRUG PENETRATION; INTESTINE ABSORPTION; INTESTINE PERFUSION; MALE; MICELLE; NONHUMAN; RAT;

EID: 84876754894     PISSN: 12264512     EISSN: 20933827     Source Type: Journal    
DOI: 10.4196/kjpp.2013.17.1.9     Document Type: Article

References (24)

1. Sakuma S, Tanno FK, Masaoka Y, Kataoka M, Kozaki T, Kamaguchi R, Kokubo H, Yamashita S. Effect of administration site in the gastrointestinal tracton bioavailability of poorly absorbed drugstaken after a meal. J Control Release. 2007;118:59-64.
2. Persson EM, Nordgren A, Forsell P, Knutson L, Ohgren C, Forssén S, Lennernäs H, Abrahamsson B. Improved understanding of the effect of food on drug absorption and bioavailability for lipophilic compounds using an intestinal pig perfusion model. Eur J Pharm Sci. 2008;34:22-29.
3. Boyd BJ, Khoo SM, Whittaker DV, Davey G, Porter CJ. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats. Int J Pharm. 2007;340:52-60.
4. Sheen PC, Khetarpal VK, Cariola CM, Rowlings CE. Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability. Int J Pharm. 1995;118: 221-227.
5. Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA, Keirns JJ. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly watersoluble LTB4 inhibitor. J Pharm Sci. 1998;87:164-169.
6. McInnes GT, Asbury MJ, Ramsay LE, Shelton JR, Harrison IR. Effect of micronization on the bioavailability and pharmacologic activity of spironolactone. J Clin Pharmacol. 1982;22: 410-417.
7. Mainardes RM, Urban MC, Cinto PO, Khalil NM, Chaud MV, Evangelista RC, Gremiao MP. Colloidal carriers for ophthalmic drug delivery. Curr Drug Targets. 2005;6:363-371.
8. O'Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci. 2002;15:405-415.
9. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: Therapeutic applications and developments. Clin Pharmacol Ther. 2008;83:761-769.
10. Schiller WR. Summary of proceedings at the 43rd annual pancreas club meeting. J Gastrointest Surg. 2009;13:2201-2211.
11. Noh JY, Park JS, Lim KM, Kim K, Bae ON, Chung SM, Shin S, Chung JH. A naphthoquinone derivative can induce anemia through phosphatidylserine exposure-mediated erythrophagocytosis. J Pharmacol Exp Ther. 2010;333:414-420.
12. Cunha-Filho MS, Dacunha-Marinho B, Torres-Labandeira JJ, Martínez-Pacheco R, Landín M. Characterization of betalapachone and methylated beta-cyclodextrin solid-state systems. AAPS Pharm Sci Tech. 2007;8:E60.
13. Li DX, Han MJ, Balakrishnan P, Yan YD, Oh DH, Joe JH, Seo Y, Kim JO, Park SM, Yong CS, Choi HG. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound. Arch Pharm Res. 2010;33: 95-101.
14. Yu JN, Zhu Y, Wang L, Peng M, Tong SS, Cao X, Qiu H, Xu XM. Enhancement of oral bioavailability of the poorly watersoluble drug silybin by sodium cholate/phospholipid-mixed micelles. Acta Pharmacol Sin. 2010;31:759-764.
15. des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Control Release. 2006;116: 1-27.
16. Suresh D, Srinivasan K. Studies on the in vitro absorption of spice principles-curcumin, capsaicin and piperine in rat intestines. Food Chem Toxicol. 2007;45:1437-1442.
17. Song NN, Li QS, Liu CX. Intestinal permeability of metformin using single-pass intestinal perfusion in rats. World J Gastroenterol. 2006;12:4064-4070.
18. Cook TJ, Shenoy SS. Intestinal permeability of chlorpyrifos using the single-pass intestinal perfusion method in the rat. Toxicology. 2003;184:125-133.
19. Kunes M, Svoboda Z, Kvtina J, Herout V, Herink J, Bajgar J. Intestinal single-pass in situ perfusion technique in rat: The influence of L-carnitine on absorption of 7-methoxytacrine. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005;149:433-435.
20. Liu J, Gong T, Wang C, Zhong Z, Zhang Z. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: Preparation and characterization. Int J Pharm. 2007;340:153-162.
21. Levitt MD, Furne JK, Levitt DG. Shaking of the intact rat and intestinal angulation diminish the jejunal unstirred layer. Gastroenterology. 1992;103:1460-1466.
22. Winne D, Görig H, Müller U. Closed rat jejunal segment in situ: Role of pre-epithelial diffusion resistance (unstirred layer) in the absorption process and model analysis. Naunyn Schmiedebergs Arch Pharmacol. 1987;335:204-215.
23. Lindahl A, Sandström R, Ungell AL, Lennernäs H. Concentration-and region-dependent intestinal permeability of fluvastatin in the rat. J Pharm Pharmacol. 1998;50:737-744.
24. Hamada T, Ikeda I, Takashima K, Kobayashi M, Kodama Y, Inoue T, Matsuoka R, Imaizumi K. Hydrolysis of micellar phosphatidylcholine accelerates cholesterol absorption in rats and Caco-2 cells. Biosci Biotechnol Biochem. 2005;69:1726-1732.